Currently, more than 15 anti-cancer nanomedicines, including lipid-based NPs, protein-drug conjugates, and metallic NPs, have been granted approval status by the U.S
Whats going on there
Rising healthcare expenditure supports growth in preventive healthcare, wellness services, personalized medicine, and IV infusion therapies
AMPK has been called the master metabolic switch of the cell
For example, in 20242025, leading firms such as Kyowa Hakko Bio, KOHJIN Life Sciences, and Lesaffre expanded their portfolios with liposomal, nano-formulated, and plant-based glutathione offerings, enhancing bioavailability, stability, and sustainability
However, this plan is *not* designed for individuals that have extremely limited mobility, cannot stand for extended periods of time, or have difficulties completing activities of daily living